| Literature DB >> 27695481 |
Emrah Celik1, Hakan Oguzturk2, Nurhan Sahin3, Muhammet Gökhan Turtay2, Fatih Oguz4, Osman Ciftci5.
Abstract
INTRODUCTION: In this study, we aimed to determine the protective effects of hesperidin, a citrus flavonoid, in a model of testicular ischemia/reperfusion injury in rats.Entities:
Keywords: hesperidin; ischemia-reperfusion injury in the rat; testicular torsion-detorsion
Year: 2015 PMID: 27695481 PMCID: PMC5016569 DOI: 10.5114/aoms.2015.47697
Source DB: PubMed Journal: Arch Med Sci ISSN: 1734-1922 Impact factor: 3.318
Study groups
| Groups | Number of subjects ( | Experimental protocol |
|---|---|---|
| Group 1: control | 7 | Surgical procedures performed, right testis removed and placed again the scrotum without application of torsion. This group was used to determine possible effects of surgical stress on the testes. |
| Group 2: LH | 7 | Surgical procedures performed, right testis removed and 50 mg/kg |
| Group 3: HH | 7 | Surgical procedures performed, right testis removed and 100 mg/kg |
| Group 4: T/D | 7 | Right testis removed and testicular torsion was applied. After a period of 1 h ischemia detorsion was applied and 4 h of reperfusion was achieved. This group was used to determine possible effects of detorsion on I/R injury. |
| Group 5: T/D + LH | 7 | Right testis removed and testicular torsion was applied. After a period of 1 h ischemia detorsion was applied and 4 h of reperfusion was achieved. 50 mg/kg |
| Group 6: T/D + HH | 7 | Right testis removed and testicular torsion was applied. After a period of 1 h ischemia detorsion was applied and 4 h of reperfusion was achieved. 100 mg/kg |
Distribution of biochemical data by group
| Groups | MDA | SOD | CAT | GSH |
|---|---|---|---|---|
| Group 1: control | 7.67 ±0.97 | 3.86 ±0.17 | 0.037 ±0.001 | 390.1 ±18.0 |
| Group 2: LH | 6.63 ±0.55 | 3.83 ±0.39 | 0.027 ±0.003 | 432.4 ±10.3 |
| Group 3: HH | 4.64 ±0.39 | 4.73 ±0.43 | 0.030 ±0.001 | 436.3 ±14.2 |
| Group 4: T/D | 11.73 ±0.59 | 1.80 ±0.24 | 0.017 ±0.001 | 311.3 ±12.4 |
| Group 5: T/D + LH | 6.48 ±0.26 | 2.70 ±0.23 | 0.025 ±0.001 | 385.3 ±19.4 |
| Group 6: T/D + HH | 6.66 ±0.83 | 3.65 ±0.26 | 0.030 ±0.002 | 380.5 ±16.8 |
| Value of | 0.001 | 0.001 | 0.001 | 0.001 |
Indicates means significantly different from control group (p < 0.05);
indicates significant difference between group 4 and other treatment groups;
indicates significant difference between group 5 and other treatment groups.
Indicates significant difference between group 6 and other treatment groups.
Figure 1Control group shows normal testicular seminiferous tubules and germinal cells (H + E, 200×)
Figure 2T/D-LH Group. Grade II testicular changes with narrow atrophied seminiferous tubules. (H + E, 100×)
Figure 3T/D-HH Group Grade II testicular tissue showing obvious loss of cohesion (H + E, 200×)
Figure 4T/D-LH Group. Unclear boundaries of seminiferous tubule, irregular, dispersed germinal cells (grade III) (H + E, 100×)
Figure 7T/D Group. Significant coagulative necrosis in germinal cells (Grade IV) (H + E, 400×)
Histopathological evaluation of the findings
| Groups | Grade 1 | Grade 2 | Grade 3 | Grade 4 | Edema | Congestion |
|---|---|---|---|---|---|---|
| Group 1: control | 7/7 | 0/7 | 0/7 | 0/7 | 6/7 | 0/7 |
| Group 2: LH | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 |
| Group 3: HH | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 |
| Group 4: T/D | 0/7 | 2/7 | 1/7 | 4/7 | 5/7 | 2/7 |
| Group 5: T/D-LH | 0/7 | 5/7 | 2/7 | 0/7 | 4/7 | 3/7 |
| Group 6: T/D-HH | 3/7 | 3/7 | 1/7 | 0/7 | 4/7 | 3/7 |